MedTrace Logo

Recurrent Throat Infections and Tonsillectomy

NCT00547391 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2012-04-19

No results posted yet for this study

Summary

The purpose of this study is to find out if tonsillectomy reduces the short-term risk of having an objectively confirmed (sequential changes in serum crp and procalcitonin levels) delayed pharyngitis episode among patients suffering from recurrent pharyngitis episodes. Other aims are to find out the effect of tonsillectomy to reduce the number of pharyngitis episodes or symptoms. Still, the possible disadvantages of tonsillectomy and changes in the quality of life after tonsillectomy among these patients are examined.

Conditions

  • Tonsillitis
  • Pharyngitis

Interventions

PROCEDURE

Tonsillectomy

Tonsillectomy under general anesthesia as a day surgery using diathermy or blunt dissection. Follow up started from the day of surgery.

OTHER

no intervention

No intervention (controls). Follow up started from the day of randomization.

Sponsors & Collaborators

  • Oulu University Hospital

    lead OTHER

Principal Investigators

  • Petri Koivunen, MD · Dept of Otolaryngology, University of Oulu, Finland

  • Aila Kristo, MD · Dept of Otolaryngology, University of Oulu, Finland

  • Onni Niemelä · Laboratory, University of Oulu, Finland

  • Markku Koskela · Microbiological Laboratory, University of Oulu, Finland

  • Timo J Koskenkorva, MD · Dept of Otolaryngology, University of Oulu, Finland

  • Olli-Pekka Alho, professor · Dept of Otolaryngology, University of Oulu, Finland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-12-31
Completion
2011-06-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00547391 on ClinicalTrials.gov